The effects of medication on intraocular pressure in children with attention deficit hyperactivity disorder: A prospective study


Guvenmez O., ÇUBUK M. Ö., GÜNEŞ S.

Journal of Population Therapeutics and Clinical Pharmacology, cilt.27, sa.2, 2020 (ESCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 2
  • Basım Tarihi: 2020
  • Doi Numarası: 10.15586/jptcp.v27i2.665
  • Dergi Adı: Journal of Population Therapeutics and Clinical Pharmacology
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Anahtar Kelimeler: attention deficit hyperactivity disorder, methylphenidate, atomoxetine, intraocular pressure, glaucoma
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric conditions in childhood. Psychopharmacological therapy is an effective treatment for ADHD. In this study, we primarily aim to investigate the effects of psychopharmacological agents on intraocular pressure (IOP) in children with ADHD. The sample included 82 children with ADHD and 36 healthy children aged between 8 and 12 years who were referred to the Department of Child and Adolescent Psychiatry in Hatay State Hospital, Hatay, Turkey. Children with ADHD were divided into two groups according to the medication used: methylphenidate (MPH) group and atomoxetine (ATX) group. Before treatment and after 1-and 6-month treatment period, IOP was measured by Goldmann applanation tonometry. There were no statistical differences in terms of age, gender, and IOP between the three groups (P > 0.05). After 1-and 6-month treatment, the IOP did not change significantly between baseline and 1 month or 6 months (P > 0.05). Children with ADHD may have an IOP similar to healthy children. Six-month treatment with MPH or ATX may not cause significant changes in IOP.